Use of ergonovine to identify esophageal spasm in patients with chest pain

G. L. Eastwood, B. H. Weiner, W. J. Dickerson, E. M. White, I. S. Ockene, C. I. Haffajee, Joseph S Alpert

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

We administered intravenous ergonovine maleate to 14 patients with chest pain resembling angina pectoris and to four healthy volunteers. Five of the patients experienced their typical chest pain after ergonovine, and manometric signs of esophageal spasm also developed. The remaining nine patients and the four volunteers did not experience chest pain, but all subjects except one had some symptomatic response to ergonovine, including chest warmth or heaviness, headache, mild choking sensation, facial numbness, flushing, or nausea. Two of the nine patients and one of the four volunteers developed manometric signs of esophageal spasm after ergonovine but experienced no chest pain. Intravenous ergonovine may be useful to identify esophageal spasm in selected patients with chest pain who have normal coronary arteries or in whom coronary artery disease is insufficient to explain symptoms. However, we believe that the potential risks of ergonovine do not justify its routine use as a provocative agent for esophageal spasm.

Original languageEnglish (US)
Pages (from-to)768-771
Number of pages4
JournalAnnals of Internal Medicine
Volume94
Issue number6
StatePublished - 1981
Externally publishedYes

Fingerprint

Diffuse Esophageal Spasm
Ergonovine
Chest Pain
Volunteers
Hypesthesia
Angina Pectoris
Airway Obstruction
Nausea
Headache
Coronary Artery Disease
Coronary Vessels
Healthy Volunteers
Thorax

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Eastwood, G. L., Weiner, B. H., Dickerson, W. J., White, E. M., Ockene, I. S., Haffajee, C. I., & Alpert, J. S. (1981). Use of ergonovine to identify esophageal spasm in patients with chest pain. Annals of Internal Medicine, 94(6), 768-771.

Use of ergonovine to identify esophageal spasm in patients with chest pain. / Eastwood, G. L.; Weiner, B. H.; Dickerson, W. J.; White, E. M.; Ockene, I. S.; Haffajee, C. I.; Alpert, Joseph S.

In: Annals of Internal Medicine, Vol. 94, No. 6, 1981, p. 768-771.

Research output: Contribution to journalArticle

Eastwood, GL, Weiner, BH, Dickerson, WJ, White, EM, Ockene, IS, Haffajee, CI & Alpert, JS 1981, 'Use of ergonovine to identify esophageal spasm in patients with chest pain', Annals of Internal Medicine, vol. 94, no. 6, pp. 768-771.
Eastwood GL, Weiner BH, Dickerson WJ, White EM, Ockene IS, Haffajee CI et al. Use of ergonovine to identify esophageal spasm in patients with chest pain. Annals of Internal Medicine. 1981;94(6):768-771.
Eastwood, G. L. ; Weiner, B. H. ; Dickerson, W. J. ; White, E. M. ; Ockene, I. S. ; Haffajee, C. I. ; Alpert, Joseph S. / Use of ergonovine to identify esophageal spasm in patients with chest pain. In: Annals of Internal Medicine. 1981 ; Vol. 94, No. 6. pp. 768-771.
@article{ff445c3a894a4bc8859e0243fe644a15,
title = "Use of ergonovine to identify esophageal spasm in patients with chest pain",
abstract = "We administered intravenous ergonovine maleate to 14 patients with chest pain resembling angina pectoris and to four healthy volunteers. Five of the patients experienced their typical chest pain after ergonovine, and manometric signs of esophageal spasm also developed. The remaining nine patients and the four volunteers did not experience chest pain, but all subjects except one had some symptomatic response to ergonovine, including chest warmth or heaviness, headache, mild choking sensation, facial numbness, flushing, or nausea. Two of the nine patients and one of the four volunteers developed manometric signs of esophageal spasm after ergonovine but experienced no chest pain. Intravenous ergonovine may be useful to identify esophageal spasm in selected patients with chest pain who have normal coronary arteries or in whom coronary artery disease is insufficient to explain symptoms. However, we believe that the potential risks of ergonovine do not justify its routine use as a provocative agent for esophageal spasm.",
author = "Eastwood, {G. L.} and Weiner, {B. H.} and Dickerson, {W. J.} and White, {E. M.} and Ockene, {I. S.} and Haffajee, {C. I.} and Alpert, {Joseph S}",
year = "1981",
language = "English (US)",
volume = "94",
pages = "768--771",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "6",

}

TY - JOUR

T1 - Use of ergonovine to identify esophageal spasm in patients with chest pain

AU - Eastwood, G. L.

AU - Weiner, B. H.

AU - Dickerson, W. J.

AU - White, E. M.

AU - Ockene, I. S.

AU - Haffajee, C. I.

AU - Alpert, Joseph S

PY - 1981

Y1 - 1981

N2 - We administered intravenous ergonovine maleate to 14 patients with chest pain resembling angina pectoris and to four healthy volunteers. Five of the patients experienced their typical chest pain after ergonovine, and manometric signs of esophageal spasm also developed. The remaining nine patients and the four volunteers did not experience chest pain, but all subjects except one had some symptomatic response to ergonovine, including chest warmth or heaviness, headache, mild choking sensation, facial numbness, flushing, or nausea. Two of the nine patients and one of the four volunteers developed manometric signs of esophageal spasm after ergonovine but experienced no chest pain. Intravenous ergonovine may be useful to identify esophageal spasm in selected patients with chest pain who have normal coronary arteries or in whom coronary artery disease is insufficient to explain symptoms. However, we believe that the potential risks of ergonovine do not justify its routine use as a provocative agent for esophageal spasm.

AB - We administered intravenous ergonovine maleate to 14 patients with chest pain resembling angina pectoris and to four healthy volunteers. Five of the patients experienced their typical chest pain after ergonovine, and manometric signs of esophageal spasm also developed. The remaining nine patients and the four volunteers did not experience chest pain, but all subjects except one had some symptomatic response to ergonovine, including chest warmth or heaviness, headache, mild choking sensation, facial numbness, flushing, or nausea. Two of the nine patients and one of the four volunteers developed manometric signs of esophageal spasm after ergonovine but experienced no chest pain. Intravenous ergonovine may be useful to identify esophageal spasm in selected patients with chest pain who have normal coronary arteries or in whom coronary artery disease is insufficient to explain symptoms. However, we believe that the potential risks of ergonovine do not justify its routine use as a provocative agent for esophageal spasm.

UR - http://www.scopus.com/inward/record.url?scp=0019434966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019434966&partnerID=8YFLogxK

M3 - Article

C2 - 7235419

AN - SCOPUS:0019434966

VL - 94

SP - 768

EP - 771

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 6

ER -